Friday, December 13, 2019
-18 °c
StockWatch247
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap
No Result
View All Result
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap
No Result
View All Result
StockWatch247
No Result
View All Result
Home Stocks To Watch

Stocks To Watch: Novartis AG (NYSE: NVS) Agrees to Buy Medicine Co. in a $6.8 Billion Deal

by Stock Watch 247 Team
November 25, 2019
in Stocks To Watch
2 min read
0
Stocks To Watch: Novartis AG (NYSE: NVS) Agrees to Buy Medicine Co. in a $6.8 Billion Deal
Share on FacebookShare on Twitter

Stocks To Watch: Novartis AG [NYSE: NVS] is making headlines today. This follows news that the company had agreed to buy Medicines Co. in a $6.8 billion deal. The acquisition of this cholesterol drug maker is another promising addition to Novartis, in a series of acquisitions under CEO Vas Narasimhan. The deal will give Novartis access to the experimental cholesterol drugs, Inclisiran. Through it, the company will also have access to a wide array of other drugs including Entresto, a treatment for heart failure.

Under the deal, shareholders of Medicines Co. will get $85, representing a 45% premium on the level it closed at on the 18th of November, when news of talks between the two companies broke out. While the deal is valued at $6.8 billion, on a diluted basis, it is worth about $9.7 billion.

RELATED POSTS

Aprea Therapeutics (NASDAQ: APRE) Makes New Highs After Presentation on Phase lb/II Clinical Trial for APE-246

Synthorx Inc (NASDAQ: THOR) Accepts Buyout Deal From Sanofi at a 172% Premium

Under its current CEO, Novartis has taken an acquisition strategy to better its presence in the treatment of cancer and rare diseases.  In a call with investors last week, the company’s CEO stated that this deal has the potential to become a major sales driver for Novartis, and will boost the company’s profit margins in its innovative drugs division.  

Besides this deal, Novartis is also releasing to the market Zolgensma. This is a gene therapy for treating muscle disease. The company gained access to this treatment after it bought AveXis Inc last year for $8.7 billion.

Looking at the charts, the company had little movement on Friday’s close. It closed the day with a slight loss of 0.06%. Volumes in the day stood at 906.98k. In today’s session, news of the company’s acquisition could play into the price action.

About Novartis AG 

Novartis AG is a researcher, manufacturer, and marketer of healthcare products all across the world. The company also has agreements with a number of organizations that include Bristol-Myers Squibb and the University of California, Berkeley. It has its headquarters in Basel, Switzerland.

Tags: Learn Stock Trading ChartsNYSE: NVSStock Trading StrategiesStocks to Watch
ShareTweetShare

Related Posts

Aprea Therapeutics (NASDAQ: APRE) Makes New Highs After Presentation on Phase lb/II Clinical Trial for APE-246
Stocks To Watch

Aprea Therapeutics (NASDAQ: APRE) Makes New Highs After Presentation on Phase lb/II Clinical Trial for APE-246

by Stock Watch 247 Team
22 hours ago

Aprea Therapeutics Inc (NASDAQ: APRE) made new highs on Wednesday to close with gains of 16.32%. This came after the...

Read more
Synthorx Inc (NASDAQ: THOR) Accepts Buyout Deal From Sanofi at a 172% Premium
Stocks To Watch

Synthorx Inc (NASDAQ: THOR) Accepts Buyout Deal From Sanofi at a 172% Premium

by Stock Watch 247 Team
4 days ago

Synthorx Inc (NASDAQ: THOR) has been on an uptrend since November. At the moment, the stock is trending on news...

Read more
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Phase 3 Studies for Lupus Nephritis a Success
Stocks To Watch

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Phase 3 Studies for Lupus Nephritis a Success

by Stock Watch 247 Team
1 week ago

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is surging in pre-market trading. At the moment, it is up by over 100% to...

Read more
Stocks To Watch: Myovant Sciences (MYOV) Grabs Wall Street’s Attention On Its Prostate Cancer Treatment
Stocks To Watch

Stocks To Watch: Myovant Sciences (MYOV) Grabs Wall Street’s Attention On Its Prostate Cancer Treatment

by Stock Watch 247 Team
3 weeks ago

Stocks To Watch: Myovant Sciences Ltd was a big gainer in Tuesday’s trading session. The stock closed the...

Read more
Stocks To Watch: Applied DNA Sciences (APDN) Surges Over 300% On Leather DNA Tagging Breakthrough
Stocks To Watch

Stocks To Watch: Applied DNA Sciences (APDN) Surges Over 300% On Leather DNA Tagging Breakthrough

by Stock Watch 247 Team
4 weeks ago

Stocks To Watch: Applied DNA Sciences was one of the biggest gainers in Tuesday’s trading session. However today...

Read more
Next Post
Active Stocks: Alibaba Group Holding (NYSE: BABA) Debuts on the Hong Stock Exchange at a Premium

Active Stocks: Alibaba Group Holding (NYSE: BABA) Debuts on the Hong Stock Exchange at a Premium

Proteostasis Therapeutics (NASDAQ: PTI) Gains As It Completes Enrollment For Treatment Study

Proteostasis Therapeutics (NASDAQ: PTI) Gains As It Completes Enrollment For Treatment Study

MOST VIEWED

  • NASDAQ: FCEL

    FuelCell Energy (FCEL) Gains by Over 10% in Pre-market Trading

    0 shares
    Share 0 Tweet 0
  • JUMIA TECHNOLOGIES AG (JMIA) After IPO Surge Ends as The Stock Sees a 13% Slump

    0 shares
    Share 0 Tweet 0
  • Amazon (AMZN) – Amazon likely to stay bullish this quarter: The fundamentals support it

    1 shares
    Share 1 Tweet 0
  • Tufin Software Technologies (TUFN) Continues to Show Strength in the Market

    2 shares
    Share 2 Tweet 0
  • Jumia Technologies AG (JMIA) Stock: Likely the Undiscovered Africa’s New ‘Gold’

    0 shares
    Share 0 Tweet 0

Stock Watch 247

Stock Watch 247 is a leading provider and publisher of stock market news, initial public offering (IPO) news, new stock listings and stocks to watch, commentary, business news, financial news and content on the USA & World Markets. Stock Watch 247 is for information only and not investment advice. Please make sure to read our Disclaimer and Privacy Policy. We may be buying or selling any stock discussed at any time.

Categories

  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap

Stocks To Watch: Silvercorp Metals (SVM) Sustains Bull Run in Spite of Market Uncertainties

Goldman Sachs Bullish on Micron Technology (MU) After Improved U.S-China Trade Deal Prospects

Outlook Therapeutics (OTLK) Up in Pre-Market Trading: A Continuation of Thursday’s Bullish Rally

Vislink (VISL) Sells Off in Pre-Market After Making a 146% Jump in Price

Brooks Automation Inc. (BRKS) – Hedge Funds Cut back Investments in Q1 but Outlook Remains Bullish

Hovnanian Enterprises (HOV) Bullish Reversal might Help its Future on the NYSE

SUBSCRIBE TO OUR FREE VIP NEWSLETTER: Get Trade Reports, Ideas, Breaking News and more!

By clicking "Subscribe" I agree to the Privacy Policy & Disclaimer presented on this site.

  • About Us
  • Our Team
  • Privacy Policy
  • Disclaimer
  • Contact Us

© 2019 StockWatch247 - Copyright © All Rights Reserved.

No Result
View All Result
  • Active Stocks
  • Earnings
  • New Issues – IPOs
  • Stocks To Watch
  • Technology
  • Top Performers
  • Small Cap

© 2019 StockWatch247 - Copyright © All Rights Reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In